0 Bedömningar

ID

22717

Beskrivning

Study part: Adverse Events Screening Visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Nyckelord

  1. 2017-06-11 2017-06-11 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

11 juni 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :


    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Adverse Events Screening Visit Mepolizumab HES NCT00086658

    Adverse Events Screening Visit

    ADVERSE EVENTS
    Beskrivning

    ADVERSE EVENTS

    Alias
    UMLS CUI-1
    C0877248
    AE's and SAE's related to study participation during the screening and Prednisone stabilization period reported?
    Beskrivning

    Adverse Events

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C0877248

    Similar models

    Adverse Events Screening Visit

    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    ADVERSE EVENTS
    C0877248 (UMLS CUI-1)
    Adverse Events
    Item
    AE's and SAE's related to study participation during the screening and Prednisone stabilization period reported?
    boolean
    C0877248 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial